August 31, 2016
Recommended Topic Related To:

Bicnu

"The U.S. Food and Drug Administration today approved Farydak (panobinostat) for the treatment of patients with multiple myeloma.

Multiple myeloma is a form of blood cancer that arises from plasma cells, a type of white blood cell, found in "...

A A A

BiCNU




Overdosage
Contraindications

OVERDOSE

No proven antidotes have been established for BiCNU (carmustine) overdosage.

CONTRAINDICATIONS

BiCNU (carmustine) should not be given to individuals who have demonstrated a previous hypersensitivity to it.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 5/5/2011

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.